Looking Beyond VEGF Suppression: Optimizing the Patient Journey

Theme:
Co-Developed Symposium
When:
6:30 AM, Saturday 17 Jun 2023 (1 hour 30 minutes)
Where:
Québec City Convention Centre - Room 205 ABC | Salle 205 ABC
How:

*Breakfast to be served from 6:00am*

 

Learning Objectives: 

At the end of this session, participants will be able to: 

  • Outline the role of the Tie-2/ang pathway in DR and nAMD
    and how it may impact patient outcomes
  • Identify the most important biomarkers
    on structural OCT that can help predict treatment
    response in DME and nAMD
  • Discuss real-world case presentations and when
    to switch patients from one agent to another
  • Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER)


CanMEDS Roles: Medical expert, scholar

Diana V. Do, MD
Diana V. Do, MD
Keynote speaker
Retina
Sunir J. Garg, MD, FACS, FASRS
Sunir J. Garg, MD, FACS, FASRS
Keynote speaker
Retina
Dr. Shaheer Aboobaker
Dr. Shaheer Aboobaker
Moderator
Scientific Planning Committee - Co-Developed Symposium
Dr. Wai-Ching Lam
Dr. Wai-Ching Lam
Moderator
Scientific Planning Committee - Co-Developed Symposium
Varun Chaudhary
Varun Chaudhary
Chair
Scientific Planning Committee Chair - Co-Developed Symposium
Dr. SriniVas Sadda
Dr. SriniVas Sadda
Speaker

Sub Sessions

Session detail
Allows attendees to send short textual feedback to the organizer for a session. This is only sent to the organizer and not the speakers.
To respect data privacy rules, this option only displays profiles of attendees who have chosen to share their profile information publicly.

Changes here will affect all session detail pages